Long-term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) With Relapsed/Refractory (r/r) Follicular Lymphoma (FL) Treated With Tisagenlecleucel in the ELARA Trial

被引：0

作者：

Dreyling, M. ^{[1
]}

Dickinson, M. ^{[2
,3
]}

Martinez-Lopez, J. ^{[4
]}

Kolstad, A. ^{[5
]}

Butler, J. ^{[6
]}

Ghosh, M. ^{[7
]}

Popplewell, L. ^{[8
]}

Chavez, J. C. ^{[9
]}

Bachy, E. ^{[10
,11
]}

Kato, K. ^{[12
]}

Harigae, H. ^{[13
]}

Kersten, M. J. ^{[14
]}

Andreadis, C. ^{[15
]}

Riedell, P. A. ^{[16
]}

Ho, P. J. ^{[17
,18
]}

Perez-Simon, J. A. ^{[19
]}

Chen, A. I. ^{[20
]}

Nastoupil, L. J. ^{[21
]}

Tresckow, B. V. ^{[22
,23
,24
]}

Ferreri, Maria A. J. ^{[25
]}

Teshima, T. ^{[26
]}

Patten, P. E. ^{[27
,28
]}

McGuirk, J. P. ^{[29
]}

Petzer, A. ^{[30
]}

Offner, F. ^{[31
]}

Viardot, A. ^{[32
]}

Zinzani, P. L. ^{[33
,34
]}

Malladi, R. ^{[35
]}

Paule, I. ^{[36
]}

Zia, A. ^{[36
]}

Awasthi, R. ^{[37
]}

Han, X. ^{[38
]}

Germano, D. ^{[36
]}

O'Donovan, D. ^{[39
]}

Ramos, R. ^{[38
]}

Masood, A. ^{[38
]}

Thieblemont, C. ^{[40
]}

Fowler, N. ^{[41
,42
]}

Schuster, S. J. ^{[43
]}

机构：

[1] LMU Klinikum, Med Klin 3, Munich, Germany

[2] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[3] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[4] Univ Complutense, Hosp 12 Octubre, Madrid, Spain

[5] Oslo Univ Hosp, Oslo, Norway

[6] Royal Brisbane Hosp, Herston, Qld, Australia

[7] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA

[8] City Hope Comprehens Canc Ctr, Duarte, CA USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematologyy, Tampa, FL USA

[10] Hosp Civils Lyon, Lyon, France

[11] Univ Claude Bernard Lyon 1, Lyon, France

[12] Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Fukuoka, Japan

[13] Tohoku Univ Hosp, Sendai, Miyagi, Japan

[14] Univ Amsterdam, Dept Hematol, Ctr Canc, Amsterdam UMC, Amsterdam, Netherlands

[15] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[16] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[17] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[18] Univ Sydney, Camperdown, NSW, Australia

[19] Univ Seville, Inst Biomed Sevilla, Univ Hosp Virgen Rocio, Dept Hematol, Seville, Spain

[20] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[21] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[22] Univ Cologne, Med Fac, Dept Internal Med 1, Cologne, Germany

[23] Univ Cologne, Dept Internal Med 1, Univ Hosp Cologne, Cologne, Germany

[24] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany

[25] IRCCS San Raffaele Sci Inst, Lymphoma Unit, Milan, Italy

[26] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[27] Kings Coll London, Ctr Comprehens Canc, London, England

[28] Kings Coll Hosp London, Dept Haematol, London, England

[29] Univ Kansas Hosp & Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA

[30] Ordensklinikum Linz, Internal Med Hematol Stem Cell Transplantat 1, Hemostaseol & Med Oncol, Barmherzige Schwestern Elisabethinen, Linz, Austria

[31] UZ Gent, Ghent, Belgium

[32] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[33] IRCCS Azienda Ospedaliero Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[34] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy

[35] Cambridge Univ Hosp NHS Fdn Trust, Basel, Switzerland

[36] Novartis Pharma AG, Basel, Switzerland

[37] Novartis Inst BioMed Res, E Hanover, NJ USA

[38] Novartis Pharmaceut, E Hanover, NJ USA

[39] Novartis Pharmaceut, Dublin, Ireland

[40] Hop St Louis, Paris, France

[41] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[42] BostonGene, Waltham, MA USA

[43] Univ Penn, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1085

引用

页码：306 / 308

页数：3

共 50 条

[41] Long-term responses in patients with relapsed or refractory follicular lymphoma treated with yttrium 90 ibritumomab tiuxetan (Zevalin)
Macklis, R
Molina, A
Pohlman, B
Gordon, L
Wang, H
Saville, MW
Witzig, T
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S542 - S543
[42] Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial
Opat, Stephen
Tedeschi, Alessandra
Hu, Bei
Linton, Kim M.
McKay, Pamela
Chan, Henry
Jin, Jie
Sun, Mingyuan
Sobieraj-Teague, Magdalena
Zinzani, Pier Luigi
Browett, Peter J.
Ke, Xiaoyan
Portell, Craig A.
Thieblemont, Catherine
Ardeshna, Kirit
Bijou, Fontanet
Walker, Patricia
Hawkes, Eliza
Ho, Shir-Jing
Zhou, Keshu
Liang, Zhiyu
Xu, Jianfeng
Tankersley, Chris
Delarue, Richard
Co, Melannie
Trotman, Judith
BLOOD, 2022, 140
[43] Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (Ha) for Relapsed/Refractory Follicular Lymphoma (FL)
Jagadeesh, Deepa
Rybicki, Lisa
Abounader, Donna
Dean, Robert M.
Hill, Brian
Liu, Hien
Sobecks, Ronald M.
Hamilton, Betty Ky
Gerds, Aaron
Ferraro, Christina
Starn, Jamie
Winslow, Victoria
Pohlman, Brad
Kalaycio, Matt E.
Bolwell, Brian
Majhail, Navneet S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S223 - S224
[44] Myc Expression and Tumor-Infiltrating T Cells Are Associated with Response in Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Treated with Tisagenlecleucel in the Juliet Trial
Jaeger, Ulrich
Bishop, Michael R.
Salles, Gilles
Schuster, Stephen J.
Maziarz, Richard T.
Han, Xia
Savchenko, Alexander
Roscoe, Nathan
Orlando, Elena
Knoblock, Dawson
Tiwari, Ranjan
Pacaud, Lida Bubuteishvili
Corradini, Paolo
BLOOD, 2020, 136
[45] Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP
Strati, Paolo
Fowler, Nathan
Pina-Oviedo, Sergio
Medeiros, L. Jeffrey
Overman, Michael J.
Romaguera, Jorge E.
Nastoupil, Loretta
Wang, Michael
Hagemeister, Fredrick B.
Rodriguez, Alma
Oki, Yasuhiro
Westin, Jason
Turturro, Francesco
Neelapu, Sattva S.
Fayad, Luis
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01) : E103 - E108
[46] Efficacy and safety of duvelisib, a phosphoinositide 3 kinase (PI3K) δ and γ inhibitor, in Chinese patients (pts) with relapsed/refractory follicular lymphoma (R/R FL): A single-arm, open-label, multicenter, phase. clinical trial.
Zheng, Zhong
Gao, Yuhuan
Song, Yongping
Qian, Ying
Jing, Hongmei
Liu, Tingbo
Zhang, Lei
Sun, Xiuhua
Zhang, Yang
Lin, Li'e
Yao, Hongxia
Zhang, Huilai
Jin, Jie
Yang, Xiugao
Yuan, Jing
Yan, Xin
Peng, Wenjuan
Bai, Bin
Zhang, Hengyi
Zhao, Weili
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[47] EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL
Vose, Julie
Vitolo, Umberto
Lugtenburg, Pieternella
Chamuleau, Martine E. D.
Linton, Kim M.
Thieblemont, Catherine
Sonnevi, Kristina
Jurczak, Wojciech
Olszewski, Adam J.
Awan, Farrukh Tauseef
Okada, Craig Y.
Feldman, Tatyana A.
Hutchings, Martin
Favaro, Elena
Hoehn, Daniela
Li, Zhu
Conlon, Rebekah
Sancho, Juan-Manuel
Chavez, Julio C.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[48] Rituximab maintenance therapy (RM) for relapsed/refractory follicular lymphoma (FL): Long-term economic impact in the French setting
Brice, P.
Miadi-Fargier, H.
Le Pen, C.
Pacull, A.
Coudray-Omnes, C.
Deconinck, E.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[49] EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab with Rituximab and Lenalidomide (R 2) Vs R 2 Alone in Patients with Relapsed or Refractory Follicular Lymphoma
Falchi, Lorenzo
Morschhauser, Franck
Linton, Kim
Huang, Huiqiang
Galderisi, Faith
Quadri, Syed
Zeng, Lingmin
Hoehn, Daniela
Seymour, John F.
BLOOD, 2023, 142
[50] Rituximab (R) in combination with fludarabine (F) and cyclophosphamide (C) in relapsed follicular lymphoma (FL) patients (pts). Final results of FC plus R phase II trial by the GISL.
Sacchi, Stefano
Pozzi, Samantha
Marcheselli, Raffaella
Luminari, Stefano
Federico, Massimo
Tucci, Alessandra
Merli, Francesco
Orsucci, Loretta
Cervetti, Giulia
Occhini, Ubaldo
Liberati, Marina
Callea, Vincenzo
Brugiatelli, Maura
Baldini, Luca
BLOOD, 2006, 108 (11) : 782A - 782A

← 1 2 3 4 5 →